Unknown

Dataset Information

0

Selective targeting of the ?5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling.


ABSTRACT: The clinical need for novel bronchodilators for the treatment of bronchoconstrictive diseases remains a major medical issue. Modulation of airway smooth muscle (ASM) chloride via GABAA receptor activation to achieve relaxation of precontracted ASM represents a potentially beneficial therapeutic option. Since human ASM GABAA receptors express only the ?4- and ?5-subunits, there is an opportunity to selectively target ASM GABAA receptors to improve drug efficacy and minimize side effects. Recently, a novel compound (R)-ethyl8-ethynyl-6-(2-fluorophenyl)-4-methyl-4H-benzo[f]imidazo[1,5-a][1,4] diazepine-3-carboxylate (SH-053-2'F-R-CH3) with allosteric selectivity for ?5-subunit containing GABAA receptors has become available. We questioned whether this novel GABAA ?5-selective ligand relaxes ASM and affects intracellular calcium concentration ([Ca(2+)]i) regulation. Immunohistochemical staining localized the GABAA ?5-subunit to human ASM. The selective GABAA ?5 ligand SH-053-2'F-R-CH3 relaxes precontracted intact ASM; increases GABA-activated chloride currents in human ASM cells in voltage-clamp electrophysiology studies; and attenuates bradykinin-induced increases in [Ca(2+)]i, store-operated Ca(2+) entry, and methacholine-induced Ca(2+) oscillations in peripheral murine lung slices. In conclusion, selective subunit targeting of endogenous ?5-subunit containing GABAA receptors on ASM may represent a novel therapeutic option to treat severe bronchospasm.

SUBMITTER: Gallos G 

PROVIDER: S-EPMC4421780 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Selective targeting of the α5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling.

Gallos George G   Yocum Gene T GT   Siviski Matthew E ME   Yim Peter D PD   Fu Xiao Wen XW   Poe Michael M MM   Cook James M JM   Harrison Neil N   Perez-Zoghbi Jose J   Emala Charles W CW  

American journal of physiology. Lung cellular and molecular physiology 20150206 9


The clinical need for novel bronchodilators for the treatment of bronchoconstrictive diseases remains a major medical issue. Modulation of airway smooth muscle (ASM) chloride via GABAA receptor activation to achieve relaxation of precontracted ASM represents a potentially beneficial therapeutic option. Since human ASM GABAA receptors express only the α4- and α5-subunits, there is an opportunity to selectively target ASM GABAA receptors to improve drug efficacy and minimize side effects. Recently  ...[more]

Similar Datasets

| S-EPMC3647697 | biostudies-literature
| S-EPMC3458840 | biostudies-literature
| S-EPMC5702405 | biostudies-literature
| S-EPMC1894896 | biostudies-literature
| S-EPMC4003869 | biostudies-literature
| S-EPMC5495950 | biostudies-literature
| S-EPMC3066567 | biostudies-literature
| S-EPMC2911342 | biostudies-literature
| S-EPMC3262669 | biostudies-literature
| S-EPMC5008275 | biostudies-literature